期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

小鼠乳腺癌实验动物模型中树突状细胞的功能检测及意义 被引量：1

Functional detection and its significance of dendritic cells in experimental model of murine mammary carcinoma
下载PDF
导出
摘要 目的观察在肿瘤生长过程中DCs的功能是否存在变化,并探讨其意义。方法建立小鼠乳腺癌动物模型,用FACS分析荷瘤早、晚期时间点肿瘤浸润淋巴细胞中DCs的比例及其MHC-Ⅱ类分子和协同刺激分子CD80、CD86的表达;用ELISA法检测DCs的细胞因子IL-4、IL-10、IFN-γ和TNF-α的分泌情况;观察DCs对CD4+T细胞增殖及对CD8+T细胞杀伤功能的影响。结果与荷瘤早期相比,荷瘤晚期肿瘤浸润淋巴细胞中DCs的比例从11.76±2.3%增加到17.45±3.2%(p<0.05);晚期DCs下调表达MHC分子及协同刺激分子CD86,而上调表达IL-4、IL-10;晚期DCs刺激CD4+T细胞增值的能力明显减弱,并且对CD8+T细胞的杀伤能力的刺激作用也显著降低。结论随着荷瘤时间的延长,DCs的成熟度及其对T淋巴细胞的免疫刺激作用逐渐降低,这可能与肿瘤的免疫逃逸密切相关。 Objective To elucidate the functional changes of dendritic cells during the tumor progress and its significance in tumor immunity. Methods An experimental animal model of mouse mammary carcinoma was established. The percentage of CD11c^＋ DCs in tumor infiltration lymphocytes in the early and late stage of tumor progress was detected by FACS. Then the expression of MHC-class Ⅱ molecule and co-stimulatory molecules CD80 and CD86 on CD11c^＋ DCs also were analyzed. Furthermore, the cytokine secretion including IL-4, IL-10, IFN-γ and TNF-α from CD11c^＋ DCs was determined by ELISA. Finally, the effects of CD11c^＋ DCs on the proliferation of CD4^＋T cells, as well as the cytotoxicity of CD8^＋T cells were determined. Results The percentage of CD11c^＋ DCs in the late stage of tumor progress was significantly higher than that in the early stage （p〈0.05）, which were 17.45±3.2% and 11.76±2.3% respectively.Furthermore, the expression of MHC-class Ⅱ molecule and the co-stimulatory molecules on CD11c^＋ DCs decreased significantly in the late stage compared with that in the early stage. On the contrary, IL-4 and IL-10 secretion of CD11c^＋ DCs increased dramatically in the late stage of tumor progress. Finally, the stimulatory effects of CD11c^＋DCs on the proliferation of CD4^＋ T cells, as well as the cytotoxicity of CD8^＋ T cells, decreased obviously in the late stage of tumor progress compared with that in the early stage. Conclusions The maturation status and the stimulatory effects of CD11c^＋ DCs gradually decreased during the tumor progression, which might be closely related to the immune escape of tumor.
作者 徐林 张忆雄 周涯 罗军敏 姚新生 汤贤英 孙万邦
机构地区 遵义医学院免疫教研室 遵义医学院医学物理学教研室
出处 《遵义医学院学报》 2008年第2期116-119,共4页 Journal of Zunyi Medical University
关键词 免疫逃逸 树突状细胞 肿瘤免疫 immune escape dendritic cells tumor immunity
分类号 R392.11 [医药卫生—免疫学]
  • 相关文献

参考文献8

  • 1Steinman RM, Kaplan G, Witmer MD, et al. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro [J]. J Exp Med,1979,149 (1):1-16.
  • 2Chan CW, Crafton E, Fan HN, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity [J]. Nat Med, 2006, 12(2):207-13.
  • 3Perrot I, Blanchart D, Freymond N, et al. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage [J].J Immunol, 2007,178(5):2763-9.
  • 4Ghiringhelli F, Puig PE, Roux S, et al. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation [J].J Exp Med, 2005, 202(7):919-29.
  • 5徐林,蒋正刚,李宝华,熊思东.小鼠乳腺癌实验动物模型中CD4^+ CD25^+调节性T细胞的变化及意义[J].复旦学报（医学版）,2006,33(6):736-740. 被引量：13
  • 6Lecoeur H, Fevrier M, Gareia S, et al. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated eytotoxieity [J]. J Immunol Methods, 2001, 253(1-2):177.
  • 7Baleeiro RB, Anselmo LB, Soares FA, et al. High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-alpha in lung cancer [J]. Cancer Immunoi Immunother, 2008, 19(2):235-239.
  • 8Gottfried E, Kreutz M, Mackensen A. Tumor-induced modulation of dendritic cell function [J]. Cytokine Growth Factor Rev, 2007, 19(1):65-77.

二级参考文献20

  • 1Bach JF.Regulatory T cells under scrutiny[J].Nat Rev Immunol,2003,3(3):189
  • 2Von Boehmer H.Mechanisms of suppression by suppressor T cells[J].Nat Immunol,2005,6 (4):338
  • 3Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155(3):1151
  • 4Stoop JN,van der Molen RG,Baan CC,et al.Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[J].Hepatology,2005,41(4):771
  • 5Terabe M,Berzofsky JA.Immunoregulatory T cells in tumor immunity[J].Curr Opin Immunol,2004,16(2):157
  • 6Pulaski BA,Ostrand-Rosenberg S.Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class Ⅱ and B7.1 cell-based tumor vaccines[J].Cancer Res,1998,58(7):1486
  • 7Pulaski BA,Terman DS,Khan S,et al.Cooperativity of Staphylococcal aureus enterotoxin B superantigen,major histocompatibility complex class Ⅱ,and CD80 for immunotherapy of adv-anced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model[J].Cancer Res,2000,60(10):2710
  • 8Lecoeur H,Fevrier M,Garcia S,et al.A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity[J].J Immunol Methods,2001,253(1-2):177
  • 9Hiura T,Kagamu H,Miura S,et al.Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression[J].J Immunol,2005,175(8):5058
  • 10Grossman WJ,Verbsky JW,Barchet W,et al.Human T regulatory cells can use the perforin pathway to cause autologous target cell death[J].Immunity,2004,21(4):589

共引文献12

同被引文献13

  • 1Atanackovic D, Nierhaus A, Neumeier M, et al. 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases [J]. Cancer Immunol Immunother, 2002, 1 ( 11 - 12) :603 -613.
  • 2Mukhopadhaya A, Mendecki J, Dong X, et al. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity [ J ]. Cancer Res, 2007, 67 (16) :7798 - 7806.
  • 3Atanackovic D, Pollok K, Faltz C, et al. Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes[ J]. Am J Physiol Regul Integr Comp Physiol, 2006, 290 (3) : R585 - 594.
  • 4Chan CW, Crafton E, Fan HN, et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity [J]. Nat Med, 2006, 12(2) :207 -213.
  • 5Perrot I, Blanchard D, Freymond N, et al. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage [J]. J Immunol, 2007, 178(5) :2763 -2769.
  • 6Ghiringhelli F, Puig PE, Roux S, et al. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4^+ CD25^+ regulatory T cell proliferation [ J]. J Exp Med, 2005, 202(7) :919 -929.
  • 7Ito A, ShinkaiM, Honda H, et al. Heat inducible TNF-alpha gene therapy combined with hyperthermia usingmagnefic nanoparticles as a novel tumor targeted therapy[J]. Cancer Gene Ther, 2001, 8:649 -654.
  • 8Guo J, Zhu J, Sheng X, et al. Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma [ J ]. Int J Cancer, 2007,120 ( 11 ) : 2418 - 2425.
  • 9Dvorak J, Zoul Z, Melichar B, et al. Liposomal doxorubicin combined with regional hyperthermia : reducing systemic toxicity and improving locoregional efficacy in the treatement of solid tumors[ J]. J Chemother, 2004, 16 : 34 - 36.
  • 10Baleeiro RB, Anselmo LB, Soares FA, et al. High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-alpha in lung cancer [ J]. Cancer Immunol Immunother, 2008, 19(2) :235 -239.

引证文献1

遵义医学院学报
2008年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部